Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Mergers & Acquisitions

Thoratec buys heart pump technology from Swedish firm

By Leave a Comment

Thoratec Corp. (NSDQ:THOR) has struck a deal to acquire catheter-pump technology from a Swedish company for $8.5 million in cash.

The percutaneous heart pump first developed by Getinge AB (OMX:GIND-B) is driven by an external motor using a flexible drive shaft and has shown the ability to move over 4.5 liters per minute during laboratory tests. Executives at Pleasanton, Calif.-based Thoratec said the acquired technology will be used to further development on axial-flow pumps that would be placed into the heart through minimally invasive catheter procedures.

Spire closes hemodialysis catheter business sale to C.R. Bard

By Leave a Comment

Spire Corp. (NSDQ:SPIR) closed the sale of its hemodialysis catheter business to a division of C.R. Bard (NYSE:BCR) Dec. 16, after postponing the merger several times and agreeing to accept $2.5 million less than the original offer.

In September 2009, Spire agreed to sell the seven-year-old operation to the Salt Lake City-based device maker’s Bard Access Systems division for $15 million, so it could focus on its core solar energy business.

Medtronic to pay up to $500 million for Italy’s Invatec, affiliates

By Leave a Comment

Medtronic Inc. (NYSE:MDT) agreed to acquire Italian cardiovascular device maker Invatec and a pair of its affiliates for up to $500 million.

The Minneapolis-based medical device monolith said it will buy Invatec, which makes stents, angioplasty balloons and accessories, along with Fogazzi, Invatec’s corporate predecessor, and Krauth Cardiovascular, which distributes Invatec products in Germany.

Quidel Corp. to buy Diagnostic Hybrids for $130 million

By Leave a Comment

By Mary Vanac

MedCity News logoATHENS, Ohio — Quidel Corp., the San Diego, Calif.-based company that makes point-of-care diagnostic tests, agreed to acquire Diagnostic Hybrids Inc. of Athens, Ohio, for $130 million in cash.

Started in 1983 by a group of Ohio University professors, Diagnostic Hybrids was spun out of the university to commercialize its sophisticated diagnostic tests used mostly by hospital and reference laboratories.

Thermo Fisher goes Down Under, buys out Biolab for $120 million

By Leave a Comment

Laboratory instruments giant Thermo Fisher Scientific took a step toward shoring up some softness in its analytic technologies business with its $120 million acquisition of Australia-based Biolab.

The deal extends the Waltham-based firm’s reach into the antipodes, as Biolab has a significant presence in Australia and New Zealand.

Medtronic acquires Ablation Frontiers

By Leave a Comment

MEDTRONIC COMPLETES ACQUISITION OF ABLATION FRONTIERS MINNEAPOLIS AND CARLSBAD, CALIF.
– Feb. 6, 2009 – Medtronic, Inc. (NYSE: MDT), today announced it has through an affiliated entity, completed the acquisition of privately held Ablation Frontiers, Inc. Under the terms of the agreement announced Jan. 12, 2009, the transaction includes an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.

Copyright © 2024 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy